Credit Suisse Ag Evogene Ltd. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.09 - $1.83 $62,438 - $104,827
-57,283 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.63 - $2.83 $93,371 - $162,110
57,283 New
57,283 $94,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0
View Full List

About Evogene Ltd.

EVGN Quotes by TradingView
  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $61.4M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email